Human E2F3 knockout HeLa cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
E2F3 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 19 bp deletion in exon2 and 38 bp deletion in exon2.
View Alternative Names
Transcription factor E2F3, E2F3, E2F-3, KIAA0075
- WB
Lab
Western blot - Human E2F3 knockout HeLa cell lysate (AB257415)
Lane 1 : Wild-type HeLa cell lysate 20 μg
Lane 2 : E2F3 knockout HeLa cell lysate 20 μg
Lane 3 : SH-SY5Y cell lysate 20 μg
Lane 4 : U-87 MG cell lysate 20 μg
False colour image of Western blot : Anti-E2F3 antibody staining at 1/500 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab152126 was shown to bind specifically to E2F3. A band was observed at 49 kDa in wild-type HeLa cell lysates with no signal observed at this size in E2F3 knockout cell line ab265362 (knockout cell lysate ab257415). To generate this image, wild-type and E2F3 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-E2F3 antibody (<a href='/en-us/products/primary-antibodies/e2f3-antibody-ab152126'>ab152126</a>) at 1/500 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
E2F3 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human E2F3 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-e2f3-knockout-hela-cell-line-ab265362'>ab265362</a>)
Lane 3:
SH-SY5Y cell lysate at 20 µg
Lane 4:
U-87 MG cell lysate at 20 µg
Predicted band size: 49 kDa
Observed band size: 49 kDa
false
- Sanger seq
Unknown
Sanger Sequencing - Human E2F3 knockout HeLa cell lysate (AB257415)
Allele-2 : 19 bp deletion in exon2
- Sanger seq
Unknown
Sanger Sequencing - Human E2F3 knockout HeLa cell lysate (AB257415)
Allele-1 : 38 bp deletion in exon2
- WB
Supplier Data
Western blot - Human E2F3 knockout HeLa cell lysate (AB257415)
Blocking and diluting buffer and concentration : 5% NFDM/TBST. The molecular weight observed is consistent with what has been described in the literature (PMID : 14716298, PMID : 36276637). In Western blot, ab320731 was shown to bind specifically to E2F3. Target of interest was observed at 52, 55 kDa in wild-type HeLa cell lysates (lane 1) with no signal observed at this size in E2F3 knockout cell line (lane 2) (lane 2, knockout cell line ab265362 / knockout cell lysate ab257415). In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-E2F3 antibody [EPR28928-50] (<a href='/en-us/products/primary-antibodies/e2f3-antibody-epr28928-50-ab320731'>ab320731</a>) at 1/1000 dilution
Lane 1:
Wild-type HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Western blot - Human E2F3 knockout HeLa cell lysate (ab257415) at 20 µg
Lane 3:
SH-SY5Y (human neuroblastoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
Jurkat (human T cell leukemia T lymphocyte from peripheral blood) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 60 kDa,55 kDa,36 kDa
false
Exposure time: 114s
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
E2F3 forms part of the E2F/DP protein complex which controls cell cycle entry and progression. Its activity facilitates the transcription of genes essential for DNA replication and synthesis. Through its interaction with retinoblastoma proteins specifically pRB and p107 E2F3 modulates cellular proliferation. This regulation is vital for maintaining normal cellular functions and growth ensuring proper cell cycle checkpoints are upheld.
Pathways
E2F3 participates in the RB/E2F signaling pathway a major controller of cell proliferation and apoptosis. This pathway serves a critical function in the decision between cell cycle progression and arrest. E2F3 interacts with cyclins and cyclin-dependent kinases (CDKs) particularly CDK2 highlighting its role in the regulation of cell cycle dynamics. It also works alongside other E2F family members such as E2F1 and E2F2 to maintain the balance between cell growth and death.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com